ACTINOGEN MEDICAL LTD (ASX: ACW)

ASX: ACW (ACTINOGEN FPO [ACW])

Kemas kini terakhir: semalam, 11:44AM

0.00 (0.00%)

Tambah ke senarai pantauan

Harga / Buku (P/B)

3.58

Julat 52 Minggu	0.019 (-9%) — 0.099 (371%)
Tarikh Pendapatan	28 Aug 2025 - 1 Sep 2025

Arah Aliran Pasaran

AISkor Stockmoo

0.3

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
ACW	67 M	-	-	3.58
CU6	694 M	-	-	4.24
CUV	569 M	0.46%	14.74	2.53
RAC	222 M	-	-	8.76
PAR	117 M	-	-	3.43
IMU	115 M	-	-	3.11

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.
Sektor	Healthcare
Industri	Biotechnology
Gaya Pelaburan	Small Core
% Dimiliki oleh Orang Dalam	16.24%
% Dimiliki oleh Institusi	6.92%

Tiada data dalam julat masa ini.

Portfolio

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Tiada saham yang memenuhi kriteria anda

Margin Keuntungan	-107.03%
Margin Operasi (TTM)	-110.44%
EPS Cair (TTM)	0.000
Pertumbuhan Hasil Suku Tahunan (YOY)	132.30%

Jumlah Hutang/Ekuiti (D/E MRQ)	1.21%
Nisbah Semasa (MRQ)	18.76
Aliran Tunai Operasi (OCF TTM)	-8.72 M
Aliran Tunai Bebas Leveraj (LFCF TTM)	-5.31 M

Pulangan Atas Aset (ROA TTM)	-31.46%
Pulangan Atas Ekuiti (ROE TTM)	-53.73%